Rentokil Initial Analyst Price Targets - Benzinga

Rentokil Initial PLC

RTONYSE

Trade with Public

Trade with Public

$22.61

-0.16-0.7%

Dern. MÀJ: Oct 26, 4:00 PM

Aperçu Actualités Prévisions de résultatsObjectifs de coursDonnées financières Sentiment Actionnariat Dividendes Comparer Options Rapport sur les stocks

Rentokil Initial Analyst Price Targets - Benzinga

Rentokil Initial Analyst Price Targets

Wall Street analyst price targets and consensus rating for Rentokil Initial (RTO).

Price Target Range — 2 Quarters

Analyst Consensus — 8 Analysts

6Buy

2Hold

Consensus RatingNeutral# Analysts8Avg. Consensus PT$32Upside to Avg. PT+41.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

Voir toutes les évaluations →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 7, 2026	Goldman Sachs	Suhasini Varanasi	Upgrade	Neutral→Buy	—
Mar 12, 2026	UBS	Nicole Manion	Upgrade	Neutral→Buy	—
Mar 10, 2026	Oppenheimer	Ian Zaffino	PT Raise	Outperform	$30→$35
Nov 21, 2025	JP Morgan	Jane Sparrow	Reinstates	Overweight	—
Oct 7, 2025	Bernstein	Will Kirkness	Upgrade	Underperform→Outperform	—
Sep 19, 2024	Redburn Atlantic	Oliver Davies	Downgrade	Buy→Neutral	—
Jul 1, 2024	UBS	—	Upgrade	Sell→Neutral	—
Mar 18, 2024	Exane BNP Paribas	—	Upgrade	Neutral→Outperform	—
Jan 24, 2024	B of A Securities	Simona Sarli	Downgrade	Buy→Neutral	$40→$29

Analyst Ratings News

PRO
UBS Upgrades Rentokil Initial to Buy

UBS analyst Nicole Manion upgrades Rentokil Initial (NYSE:RTO) from Neutral to Buy.

Benzinga Newsdesk

PRO
Oppenheimer Maintains Outperform on Rentokil Initial, Raises Price Target to $35

Oppenheimer analyst Ian Zaffino maintains Rentokil Initial (NYSE:RTO) with a Outperform and raises the price target from $30 to $35.

Benzinga Newsdesk

PRO
JP Morgan Reinstates Overweight on Rentokil Initial

JP Morgan analyst Jane Sparrow reinstates Rentokil Initial (NYSE:RTO) with a Overweight.

Benzinga Newsdesk

PRO
Bernstein Upgrades Rentokil Initial to Outperform

Bernstein analyst Will Kirkness upgrades Rentokil Initial (NYSE:RTO) from Underperform to Outperform.

Benzinga Newsdesk

PRO
Redburn Atlantic Downgrades Rentokil Initial to Neutral

Redburn Atlantic analyst Oliver Davies downgrades Rentokil Initial (NYSE:RTO) from Buy to Neutral.

Benzinga Newsdesk

PRO
UBS Upgrades Rentokil Initial to Neutral

UBS upgrades Rentokil Initial (NYSE:RTO) from Sell to Neutral.

Benzinga Newsdesk